Cargando…
Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study
OBJECTIVE: Characterize the risk for adverse pregnancy, delivery and neonatal outcomes among different advanced maternal ages (AMA). STUDY DESIGN: We conducted a population-based retrospective cohort study using data from the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample to cha...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945696/ https://www.ncbi.nlm.nih.gov/pubmed/36846599 http://dx.doi.org/10.1016/j.eurox.2023.100180 |
_version_ | 1784892191020154880 |
---|---|
author | Machado-Gédéon, Alexandre Badeghiesh, Ahmad Baghlaf, Haitham Dahan, Michael H. |
author_facet | Machado-Gédéon, Alexandre Badeghiesh, Ahmad Baghlaf, Haitham Dahan, Michael H. |
author_sort | Machado-Gédéon, Alexandre |
collection | PubMed |
description | OBJECTIVE: Characterize the risk for adverse pregnancy, delivery and neonatal outcomes among different advanced maternal ages (AMA). STUDY DESIGN: We conducted a population-based retrospective cohort study using data from the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample to characterize adverse pregnancy, delivery and neonatal outcomes among different AMA groups. Patients aged 44–45 (n = 19,476), 46–49 (n = 7528) and 50–54 years (n = 1100) were compared to patients aged 38–43 years (n = 499,655). A multivariate logistic regression analysis adjusted for statistically significant confounding variables. RESULTS: With advancing age, rates of chronic hypertension, pregestational diabetes, thyroid disease and multiple gestation increased (p < 0.001). The adjusted risk of hysterectomy and need for blood transfusion substantially increased with advancing age, reaching up to an almost 5-fold (aOR, 4.75, 95 % CI, 2.76–8.19, p < 0.001) and 3-fold (aOR, 3.06, 95 % CI, 2.31–4.05, p < 0.001) increased risk, respectively, in patients aged 50–54 years. The adjusted risk of maternal death increased 4-fold in patients aged 46–49 years (aOR, 4.03, 95 % CI, 1.23–13.17, p = 0.021). Adjusted risks of pregnancy-related hypertensive disorders, including gestational hypertension and preeclampsia, increased by 28–93 % across advancing age groups (p < 0.001). Adjusted neonatal outcomes demonstrated up to a 40 % elevated risk of intrauterine fetal demise in patients aged 46–49 years (aOR, 1.40, 95 % CI, 1.02–1.92, p = 0.04) and a 17 % increased risk of having a small for gestational age neonate in patients aged 44–45 years (aOR, 1.17, 95 % CI, 1.05–1.31, p = 0.004). CONCLUSIONS: Pregnancies at AMA are at increased risk for adverse outcomes, particularly for pregnancy-related hypertensive disorders, hysterectomy, blood transfusion, and maternal and fetal mortality. Although comorbidities associated with AMA influence the risk of complications, AMA was demonstrated to be an independent risk factor for major complications, with its impact varying across ages. This data imparts clinicians with the ability to provide more specific counseling to patients of varied AMA. Older patients seeking to conceive must be counseled regarding these risks in order to make well-informed decisions. |
format | Online Article Text |
id | pubmed-9945696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-99456962023-02-23 Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study Machado-Gédéon, Alexandre Badeghiesh, Ahmad Baghlaf, Haitham Dahan, Michael H. Eur J Obstet Gynecol Reprod Biol X Obstetrics and Maternal Fetal Medicine OBJECTIVE: Characterize the risk for adverse pregnancy, delivery and neonatal outcomes among different advanced maternal ages (AMA). STUDY DESIGN: We conducted a population-based retrospective cohort study using data from the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample to characterize adverse pregnancy, delivery and neonatal outcomes among different AMA groups. Patients aged 44–45 (n = 19,476), 46–49 (n = 7528) and 50–54 years (n = 1100) were compared to patients aged 38–43 years (n = 499,655). A multivariate logistic regression analysis adjusted for statistically significant confounding variables. RESULTS: With advancing age, rates of chronic hypertension, pregestational diabetes, thyroid disease and multiple gestation increased (p < 0.001). The adjusted risk of hysterectomy and need for blood transfusion substantially increased with advancing age, reaching up to an almost 5-fold (aOR, 4.75, 95 % CI, 2.76–8.19, p < 0.001) and 3-fold (aOR, 3.06, 95 % CI, 2.31–4.05, p < 0.001) increased risk, respectively, in patients aged 50–54 years. The adjusted risk of maternal death increased 4-fold in patients aged 46–49 years (aOR, 4.03, 95 % CI, 1.23–13.17, p = 0.021). Adjusted risks of pregnancy-related hypertensive disorders, including gestational hypertension and preeclampsia, increased by 28–93 % across advancing age groups (p < 0.001). Adjusted neonatal outcomes demonstrated up to a 40 % elevated risk of intrauterine fetal demise in patients aged 46–49 years (aOR, 1.40, 95 % CI, 1.02–1.92, p = 0.04) and a 17 % increased risk of having a small for gestational age neonate in patients aged 44–45 years (aOR, 1.17, 95 % CI, 1.05–1.31, p = 0.004). CONCLUSIONS: Pregnancies at AMA are at increased risk for adverse outcomes, particularly for pregnancy-related hypertensive disorders, hysterectomy, blood transfusion, and maternal and fetal mortality. Although comorbidities associated with AMA influence the risk of complications, AMA was demonstrated to be an independent risk factor for major complications, with its impact varying across ages. This data imparts clinicians with the ability to provide more specific counseling to patients of varied AMA. Older patients seeking to conceive must be counseled regarding these risks in order to make well-informed decisions. Elsevier 2023-02-08 /pmc/articles/PMC9945696/ /pubmed/36846599 http://dx.doi.org/10.1016/j.eurox.2023.100180 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Obstetrics and Maternal Fetal Medicine Machado-Gédéon, Alexandre Badeghiesh, Ahmad Baghlaf, Haitham Dahan, Michael H. Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study |
title | Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study |
title_full | Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study |
title_fullStr | Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study |
title_full_unstemmed | Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study |
title_short | Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study |
title_sort | adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: a population-based retrospective cohort study |
topic | Obstetrics and Maternal Fetal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945696/ https://www.ncbi.nlm.nih.gov/pubmed/36846599 http://dx.doi.org/10.1016/j.eurox.2023.100180 |
work_keys_str_mv | AT machadogedeonalexandre adversepregnancydeliveryandneonataloutcomesacrossdifferentadvancedmaternalagesapopulationbasedretrospectivecohortstudy AT badeghieshahmad adversepregnancydeliveryandneonataloutcomesacrossdifferentadvancedmaternalagesapopulationbasedretrospectivecohortstudy AT baghlafhaitham adversepregnancydeliveryandneonataloutcomesacrossdifferentadvancedmaternalagesapopulationbasedretrospectivecohortstudy AT dahanmichaelh adversepregnancydeliveryandneonataloutcomesacrossdifferentadvancedmaternalagesapopulationbasedretrospectivecohortstudy |